{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:37:56Z","timestamp":1790087876622,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.abrep.2024.100575","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T08:18:49Z","timestamp":1732695529000},"page":"100575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Do we need urine drug screens in opioid addiction treatment: An observational study on self-report versus urine drug screens"],"prefix":"10.1016","volume":"21","author":[{"given":"Alannah","family":"McEvoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myanca","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany B","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Worster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.abrep.2024.100575_b0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1651-2227.2006.00180.x","article-title":"Understanding diagnostic tests 1: Sensitivity, specificity and predictive values","volume":"96","author":"Akobeng","year":"2007","journal-title":"Acta Paediatrica"},{"issue":"9","key":"10.1016\/j.abrep.2024.100575_b0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/add.16200","article-title":"Agreement between self\u2010reported illicit drug use and biological samples: A systematic review and meta\u2010analysis","volume":"118","author":"Bharat","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.abrep.2024.100575_b0015","unstructured":"Canadian Centre on Substance Use and Addiction (2020). Methamphetamine."},{"key":"10.1016\/j.abrep.2024.100575_b0020","unstructured":"Centre for Addiction and Mental Health (2021). Opioid Agonist Therapy: A Synthesis of Canadian Guidelines for Treating Opioid Use Disorder. https:\/\/www.camh.ca\/-\/media\/files\/professionals\/canadian-opioid-use-disorder-guideline2021-pdf.pdf."},{"issue":"7","key":"10.1016\/j.abrep.2024.100575_b0025","first-page":"416","article-title":"Opioid use disorder: Medical treatment options","volume":"100","author":"Coffa","year":"2019","journal-title":"American Family Physician"},{"issue":"1","key":"10.1016\/j.abrep.2024.100575_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the US opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Molecular Psychiatry"},{"issue":"7","key":"10.1016\/j.abrep.2024.100575_b0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.5858\/arpa.2020-0716-SA","article-title":"The impact of increasing disease prevalence, false omissions, and diagnostic uncertainty on coronavirus disease 2019 (COVID-19) test performance","volume":"145","author":"Kost","year":"2021","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.abrep.2024.100575_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108404","article-title":"The cascade of care for opioid use disorder among youth in British Columbia, 2018","volume":"130","author":"Krebs","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.abrep.2024.100575_b0045","doi-asserted-by":"crossref","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","article-title":"The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome","volume":"93","author":"Marsden","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.abrep.2024.100575_b0050","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"4","author":"Mattick","year":"2002","journal-title":"Cochrane Database of Systematic Reviews (Online)"},{"issue":"3","key":"10.1016\/j.abrep.2024.100575_b0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/ADM.0000000000000220","article-title":"Utility of point of care urine drug tests in the treatment of primary care patients with drug use disorders","volume":"10","author":"McDonell","year":"2016","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.abrep.2024.100575_b0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugpo.2018.08.006","article-title":"Lacking evidence for the association between frequent urine drug screening and health outcomes of persons on opioid agonist therapy","volume":"64","author":"McEachern","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.abrep.2024.100575_b0065","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.mayocp.2016.12.007","article-title":"Clinical interpretation of urine drug tests: What clinicians need to know about urine drug screens","volume":"92","author":"Moeller","year":"2017","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"10.1016\/j.abrep.2024.100575_b0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4065\/83.1.66","article-title":"Urine drug screening: Practical guide for clinicians","volume":"83","author":"Moeller","year":"2008","journal-title":"Mayo Clinic Proceedings"},{"issue":"10","key":"10.1016\/j.abrep.2024.100575_b0075","doi-asserted-by":"crossref","first-page":"e060857","DOI":"10.1136\/bmjopen-2022-060857","article-title":"Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: A retrospective cohort study","volume":"12","author":"Morin","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.abrep.2024.100575_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-017-0130-5","article-title":"The opioid crisis: Past, present and future policy climate in Ontario, Canada","volume":"12","author":"Morin","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"8","key":"10.1016\/j.abrep.2024.100575_b0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa0810635","article-title":"Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction","volume":"361","author":"Oviedo-Joekes","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"3S","key":"10.1016\/j.abrep.2024.100575_b0090","first-page":"ES119","article-title":"Urine drug testing: Current recommendations and best practices","volume":"15","author":"Owen","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.abrep.2024.100575_b0095","doi-asserted-by":"crossref","unstructured":"Pergolizzi, J., Pappagallo, M., Stauffer, J., Gharibo, C., Fortner, N., De Jesus, M. N., Brennan, M. J., Richmond, C., Hussey, D., & (IDCSG), I. D. C. S. G. (2010). The role of urine drug testing for patients on opioid therapy. Pain Practice, 10(6), 497\u2013507.","DOI":"10.1111\/j.1533-2500.2010.00375.x"},{"issue":"1","key":"10.1016\/j.abrep.2024.100575_b0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5770\/cgj.23.420","article-title":"Canadian guidelines on opioid use disorder among older adults","volume":"23","author":"Rieb","year":"2020","journal-title":"Canadian Geriatrics Journal"},{"key":"10.1016\/j.abrep.2024.100575_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109769","article-title":"Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics","author":"Ruglass","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.abrep.2024.100575_b0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/ADM.0b013e3181a0f5dc","article-title":"Temporal and gender trends in concordance of urine drug screens and self-reported use in cocaine treatment studies","volume":"3","author":"Schuler","year":"2009","journal-title":"Journal of Addiction Medicine"},{"issue":"20","key":"10.1016\/j.abrep.2024.100575_b0115","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.abrep.2024.100575_b0120","series-title":"Stata Statistical Software: Release 17","author":"StataCorp","year":"2021"},{"issue":"5","key":"10.1016\/j.abrep.2024.100575_b0125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/14659890903431603","article-title":"Embarrassing, degrading, or beneficial: Patient and staff perspectives on urine drug testing in methadone maintenance treatment","volume":"15","author":"Strike","year":"2010","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.abrep.2024.100575_b0130","unstructured":"The College of Physicians and Surgeons of Ontario (2023). Advice to the profession: Prescribing Drugs."},{"key":"10.1016\/j.abrep.2024.100575_b0135","unstructured":"The Government of Canada (2022). Opioid- and Stimulant-related Harms in Canada."},{"key":"10.1016\/j.abrep.2024.100575_b0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fpubh.2017.00307","article-title":"Sensitivity, specificity, and predictive values: Foundations, pliabilities, and pitfalls in research and practice","volume":"5","author":"Trevethan","year":"2017","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.abrep.2024.100575_b0145","unstructured":"Trimedic Supply Network Ltd. (n.d.). FaStep Assay. https:\/\/www.trimedic-inc.com\/wp-content\/uploads\/2018\/04\/Fastep-Package-Insert.pdf."},{"issue":"10","key":"10.1016\/j.abrep.2024.100575_b0150","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.addbeh.2013.05.015","article-title":"Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants","volume":"38","author":"Wilcox","year":"2013","journal-title":"Addictive Behaviors"}],"container-title":["Addictive Behaviors Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235285322400052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235285322400052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:23:18Z","timestamp":1748928198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235285322400052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S235285322400052X"],"URL":"https:\/\/doi.org\/10.1016\/j.abrep.2024.100575","relation":{},"ISSN":["2352-8532"],"issn-type":[{"value":"2352-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do we need urine drug screens in opioid addiction treatment: An observational study on self-report versus urine drug screens","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abrep.2024.100575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100575"}}